2024-11-14
GRAIL Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c GRAIL ( NASDAQ:GRAL ) Third Quarter 2024 Results Key Financial Results Net loss: US$125.7m (flat on 3Q 2023). US$3.94... 2024-11-14 19:13:37 https://finnhub.io/api/news?id=785c2fbb19f0a081a0ac4fbb6eda32babc47abaaa50f251382f64ac88fdddc6a
2024-11-13
GRAIL Reports Third Quarter 2024 Financial Results https://media.zenfs.com/en/prnewswire.com/df6f1c041e7249704f56bfd0aaad45cf GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today reported business and financial results for the third quarter 2024. 2024-11-13 06:06:00 https://finnhub.io/api/news?id=226853ce9b95eccabc5269de7b8c8477f45df21dd60317c6d4545ea8efe09f48
2024-11-13
GRAIL : Reports Third Quarter 2024 Financial Results Form 8 K GRAIL Reports Third Quarter 2024 Financial Results Galleri Revenue Grew 52% Year-Over-Year to $25.4 Million Commercial Galleri Sales Surpassed 250,000... 2024-11-13 01:08:33 https://finnhub.io/api/news?id=95c37622e7f268aef1e60521000d3ff2c51ad94716689a272b248ad35588b16b
2024-11-05
GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum https://media.zenfs.com/en/prnewswire.com/df6f1c041e7249704f56bfd0aaad45cf GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum in New York on Thursday, Nov. 21 at 11:00 a.m. ET. 2024-11-05 06:01:00 https://finnhub.io/api/news?id=d7364a5816d988043f672d20c8ced6cdfa0c8d47a208f5e877ae8183a099adcb
더 많은 뉴스보기